Intellicell Biosciences Inc (OTC Pink - Limited Information:SVFC)

Add to Watch List

Set Alert

0.10 Data as of May 24	+0.01 / +11.11% Today’s Change	0.05 Today\|\|\|52-Week Range 0.45	-42.86% Year-to-Date

0.10

Data as of May 24

+0.01 / +11.11%

Today’s Change

0.05

Today|||52-Week Range

0.45

-42.86%

Year-to-Date

SECTOR

Technology Services

INDUSTRY

Information Technology Services

MARKET CAP

Company Description

Intellicell Biosciences, Inc. is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using a proprietary, patent pending process to separate adult autologous vascular cells ( AAVC's) from blood vessels in adult adipose tissue. The company has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. It also be seeking to develop technology licensing agreements with technology developers, universities, and international business entities. Intellicell Biosciences was founded on June 3, 2011 and is headquartered in New York, NY.

Contact Information

Intellicell Biosciences, Inc.

460 Park Avenue

New York New York 10022

P:(646) 576-8700

Investor Relations:
(646) 810-0608

www.intellicellbiosciences.com

Employees

Shareholders

Individual stakeholders	11.85%
Mutual fund holders	--
Other institutional	--

Top Executives

Steven A. Victor, MD	Chairman, President, CEO, Secretary & Treasurer
Leonard L. Mazur	Chief Operating Officer & Director
Robert J. Sexauer	Executive Vice President-Clinical Development
Anna Rhodes	Executive Vice President-Operations
Sarah R. Young	Manager-Quality Assurance

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.